Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Winter Respiratory Infections Linked to Vitamin D Levels

By BiotechDaily International staff writers
Posted on 30 Jun 2010
The increased incidence of influenza and other viral respiratory tract infections during the winter months may be linked to decreased levels of vitamin D.

Investigators at the Yale University School of Medicine (New Haven, CT, USA) determined serial monthly concentrations of 25-hydroxyvitamin D during the fall and winter 2009–2010 in 198 healthy adults, who did not know which serum components were being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators who did not know the patients' 25-hydroxyvitamin D concentrations.

Results published in the June 14, 2010, online edition of the journal PloS ONE revealed that 18 participants maintained vitamin D levels of 38 ng/mL or higher during the study period. Of this group only three (16.6 %) developed viral infections. Of the 180 other participants, 81 (45 %) developed viral infections. Those with the higher vitamin D levels also experienced a marked reduction in the number of days required to recover from their respiratory infections.

The investigators concluded that, "Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/mL or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza.”

Related Links:

Yale University School of Medicine




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).

Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.